Filipe Pinto
Post-Doc Researcher
GlycoDiagnostic/i3S
Bilateral Meetings
- Wednesday (10:00 - 12:30)
- Wednesday (14:00 - 16:30)
DescriptionDevelopment of cancer diagnostic tools based on glycotargets.
Organization Type
University / R&D Institution,
Cancer diagnostic tool development.
We are looking for companies with interest in commercializing/out licensing our diagnostic tests.
Diagnostic tool investment
We are looking for investors for validation of early stage cancer diagnostic tests.